#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA5216985	B	Inhibition of norepinephrine transporter (unknown origin) assessed as inhibition of norepinephrine reuptake	Homo sapiens	5	ALA5214950	single protein format	Scientific Literature
2.	ALA5216986	B	Inhibition of dopamine transporter (unknown origin) assessed as inhibition of dopamine reuptake	Homo sapiens	5	ALA5214950	single protein format	Scientific Literature
3.	ALA5216987	B	Binding affinity to recombinant CYP2B6 (unknown origin) assessed as spectral dissociation constant-1	Homo sapiens	5	ALA5214950	single protein format	Scientific Literature
4.	ALA5216988	B	Binding affinity to recombinant CYP2B6 (unknown origin) assessed as spectral dissociation constant-2	Homo sapiens	5	ALA5214950	single protein format	Scientific Literature
5.	ALA5216989	A	Drug metabolism assessed as CYP2B6 (unknown origin)-mediated d4-BuOH metabolite formation by measuring km	Homo sapiens	2	ALA5214950	single protein format	Scientific Literature
6.	ALA5216993	A	Drug metabolism assessed as CYP2B6 (unknown origin)-mediated d4-BuOH metabolite formation by measuring Kcat	Homo sapiens	2	ALA5214950	single protein format	Scientific Literature
7.	ALA5216996	A	Drug metabolism assessed as CYP2B6 (unknown origin)-mediated d4-BuOH metabolite formation by measuring intrinsic clearance	Homo sapiens	2	ALA5214950	single protein format	Scientific Literature
8.	ALA5216998	A	Inhibition of CYP2B6-mediated metabolism in human liver microsomes assessed as fold reduction in R,R-hydroxybupropion formation	Homo sapiens	2	ALA5214950	microsome format	Scientific Literature
9.	ALA5217000	A	Inhibition of CYP2B6-mediated metabolism in human hepatocytes assessed as reduction in R,R-hydroxybupropion formation	Homo sapiens	2	ALA5214950	cell-based format	Scientific Literature
10.	ALA5217001	A	Inhibition of CYP2B6-mediated metabolism in human hepatocytes assessed as reduction in erythro/threo-hydrobupropion formation	Homo sapiens	2	ALA5214950	cell-based format	Scientific Literature